Immunic, Inc. is trading 10.1% up at $12.89 today as it rebounds from several down days and recent weakness in the biotech and small-cap sectors.
- The stock appears to be recovering alongside a broader risk-on tone in U.S. equities following a period of sector-wide pressure.
- There are no new company-specific headlines, clinical trial readouts, or earnings releases on June 11, 2026, to explain the move.